Accuracy of serological assays for detection of recent infection with HIV and estimation of population incidence: a systematic review (Q37635429)

21 August 2017

1 reference

title

Accuracy of serological assays for detection of recent infection with HIV and estimation of population incidence: a systematic review (English)

1 reference

21 August 2017

0 references

1 reference

6

Michael Busch

1 reference

21 August 2017

10

John M Kaldor

1 reference

21 August 2017

1

Rebecca Guy

1 reference

21 August 2017

2

Judy Gold

1 reference

21 August 2017

author name string

Jesus M García Calleja

3

1 reference

21 August 2017

Andrea A Kim

4

1 reference

21 August 2017

Bharat Parekh

5

1 reference

21 August 2017

Thomas Rehle

7

1 reference

21 August 2017

John Hargrove

8

1 reference

21 August 2017

Robert S Remis

9

1 reference

21 August 2017

WHO Working Group on HIV Incidence Assays

11

1 reference

21 August 2017

publication date

1 December 2009

1 reference

Lancet Infectious Diseases

21 August 2017

published in

1 reference

21 August 2017

volume

9

1 reference

21 August 2017

issue

12

1 reference

21 August 2017

page(s)

747-759

1 reference

New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970300-7

7 January 2021

Performance characteristics of the immunoglobulin G-capture BED-enzyme immunoassay, an assay to detect recent human immunodeficiency virus type 1 seroconversion

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970300-7

7 January 2021

Development and validation of an immunoassay for identification of recent human immunodeficiency virus type 1 infections and its use on dried serum spots

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970300-7

7 January 2021

Identifying recent HIV infections using the avidity index and an automated enzyme immunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970300-7

7 January 2021

Incidence immunoassay for distinguishing recent from established HIV-1 infection in therapy-naive populations

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970300-7

7 January 2021

Improved classification of recent HIV-1 infection by employing a two-stage sensitive/less-sensitive test strategy.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970300-7

7 January 2021

Improving HIV Surveillance in Victoria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970300-7

7 January 2021

HIV type 1 incidence estimates by detection of recent infection from a cross-sectional sampling of injection drug users in Bangkok: use of the IgG capture BED enzyme immunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970300-7

7 January 2021

HIV incidence appears constant in men who have sex with men despite widespread use of effective antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970300-7

7 January 2021

Evaluation of a sensitive/less-sensitive testing algorithm using the 3A11-LS assay for detecting recent HIV seroconversion among individuals with HIV-1 subtype B or E infection in Thailand.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970300-7

7 January 2021

Estimation of HIV incidence in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970300-7

7 January 2021

Improved HIV-1 incidence estimates using the BED capture enzyme immunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970300-7

7 January 2021

Comparison of HIV type 1 incidence observed during longitudinal follow-up with incidence estimated by cross-sectional analysis using the BED capture enzyme immunoassay.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970300-7

7 January 2021

Development of a new less-sensitive enzyme immunoassay for detection of early HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970300-7

7 January 2021

Detection of recent HIV infections in African individuals infected by HIV-1 non-B subtypes using HIV antibody avidity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970300-7

7 January 2021

Comparison of the avidity index method and the serologic testing algorithm for recent human immunodeficiency virus (HIV) seroconversion, two methods using a single serum sample for identification of recent HIV infections.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970300-7

7 January 2021

Comparison of the human immunodeficiency virus (HIV) type 1-specific immunoglobulin G capture enzyme-linked immunosorbent assay and the avidity index method for identification of recent HIV infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970300-7

7 January 2021

Do tests devised to detect recent HIV-1 infection provide reliable estimates of incidence in Africa?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970300-7

7 January 2021

Investigating the utility of the HIV-1 BED capture enzyme immunoassay using cross-sectional and longitudinal seroconverter specimens from Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970300-7

7 January 2021

Seroincidence of recent human immunodeficiency virus type 1 infections in China

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970300-7

7 January 2021

A simple and inexpensive particle agglutination test to distinguish recent from established HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970300-7

7 January 2021

Effective Highly Active Antiretroviral Therapy in Patients With Primary HIV-1 Infection Prevents the Evolution of the Avidity of HIV-1-Specific Antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970300-7

7 January 2021

The effect of viral suppression on cross-sectional incidence testing in the johns hopkins hospital emergency department

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970300-7

7 January 2021

Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970300-7

7 January 2021

Performance characteristics of a new less sensitive HIV-1 enzyme immunoassay for use in estimating HIV seroincidence

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970300-7

7 January 2021

Less sensitive HIV-1 enzyme immunoassay as an adjuvant method for monitoring patients receiving antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970300-7

7 January 2021

Low estimates of HIV seroconversions among clients of a drug treatment clinic in San Francisco, 1995 to 1998.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970300-7

7 January 2021

High HIV incidence in a community with high HIV prevalence in rural South Africa: findings from a prospective population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970300-7

7 January 2021

HIV seroincidence estimates among at-risk populations in Buenos Aires and Montevideo: use of the serologic testing algorithm for recent HIV seroconversion

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970300-7

7 January 2021

Risk factors for recent HIV infection in Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970300-7

7 January 2021

Estimation of HIV incidence in San Francisco

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970300-7

7 January 2021

A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970300-7

7 January 2021

HIV incidence among injection drug users in New York City, 1990 to 2002: use of serologic test algorithm to assess expansion of HIV prevention services.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970300-7

7 January 2021

HIV incidence and HIV testing behavior in men who have sex with men: using three incidence sources, The Netherlands, 1984-2005.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970300-7

7 January 2021

Comparison of three methods to measure HIV incidence among persons seeking voluntary, anonymous counseling and testing

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970300-7

7 January 2021

A Simplified Formula for Inferring HIV Incidence from Cross-Sectional Surveys Using a Test for Recent Infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970300-7

7 January 2021

Validating marker-based incidence estimates in repeatedly screened populations

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970300-7

7 January 2021

Evaluation of diagnostic tests for infectious diseases: general principles

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970300-7

7 January 2021

Monitoring the Dynamics of the HIV Epidemic Using Assays for Recent Infection and Serotyping among New HIV Diagnoses: Experience after 2 Years in France

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970300-7

7 January 2021

10.1016/S1473-3099(09)70300-7

Identifiers

DOI

1 reference

release_nw3ewdotmnahzismhvw46uieme

21 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nw3ewdotmnahzismhvw46uieme

24 November 2022

mapped directly with Wikidata item

1 reference